Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study.
Balsam P, Ozierański K, Tymińska A, Żukowska K, Zaleska M, Szepietowska K, Maciejewski K, Peller M, Grabowski M, Lodziński P, Praska-Ogińska A, Zaboyska I, Kołtowski Ł, Kowalczuk A, Bednarski J, Filipiak KJ, Opolski G.
Balsam P, et al. Among authors: zaleska m.
Kardiol Pol. 2018;76(5):889-898. doi: 10.5603/KP.a2018.0027. Epub 2018 Jan 19.
Kardiol Pol. 2018.
PMID: 29350386
Free article.
Clinical Trial.